Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lineage Cell Therapeutics, Inc.LCTX · Entity 6045 | Director | July 01, 2026 | July 02, 2026 |
| STAAR SURGICAL COSTAA · Entity 4851 | Chief Financial Officer & EVP | August 14, 2026 | August 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lineage Cell Therapeutics, Inc.
Report date July 01, 2026 · Filed July 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.30 · Expires 2036-07-01 | Direct | 125,000 |
Reported balance
After 2026-07-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 125,000 · Balance 125,000 F1: Will vest and become exercisable on the earlier of July 1, 2027 and the date of the issuer's next annual meeting of shareholders, subject in any case to the reporting person's continuous service with the issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Will vest and become exercisable on the earlier of July 1, 2027 and the date of the issuer's next annual meeting of shareholders, subject in any case to the reporting person's continuous service with the issuer.
STAAR SURGICAL CO
Report date August 14, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,452 |
Reported balance
After 2026-08-14 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2026-08-14 · Exercise / conversion · Acquired 5,233 · Balance 41,452 |
| Common StockSEC Table I · non-derivative | Direct | 38,910 |
Reported balance
After 2026-08-14 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2026-08-14 · Tax withholding · Disposed 2,662 · Balance 38,910 F1: On May 15, 2026, the third tranche of 5,233 performance stock units ("PSUs") awarded to the Reporting Person under the 2025 PSU Program in connection with her new hire grant vested, of which 2,662 shares were withheld to satisfy taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 4,975 |
Reported balance
After 2026-08-14 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-14 · Grant · Acquired 4,975 · Balance 4,975 F2: Each restricted stock unit ("RSU") represents the right to receive one share of STAAR Surgical Company ("Company") common stock upon vesting. F3: The Reporting Person was granted Company RSUs on August 14, 2026 (the "Grant Date"). These RSUs vest as to one-third on the first anniversary of the Grant Date, and the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter. F4: The Reporting Person was granted Issuer restricted stock units (RSUs) on August 14, 2026 (the "Grant Date"). These RSUs vest as to one-third on the first anniversary of the Grant Date, and the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $26.18 · Expires 2036-08-13 | Direct | 8,952 |
Reported balance
After 2026-08-14 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-08-14 · Grant · Acquired 8,952 · Balance 8,952 F5: The Reporting Person was granted an option to purchase 8,952 shares of Company common stock. The shares underlying the option vest over three years from the Grant Date, with one-third vesting on the first anniversary of the Grant Date and the remaining two-thirds vesting in 24 substantially equal monthly installment thereafter. |
| Performance Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $26.18 · Expires 2036-08-13 | Direct | 29,159 |
Reported balance
After 2026-08-14 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-08-14 · Grant · Acquired 29,159 · Balance 29,159 F6: The Reporting Person was granted a performance option to purchase 29,159 shares of Company common stock. The shares underlying the option vest over a performance period ending on the earlier of a change in control and the 10-year anniversary of the Grant Date, subject to achievement of stock-price hurdles of $50.00, $75.00 and $100.00 per share, and time vest as to one-third on the anniversary of the Grant Date with the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter. |
| Performance Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-12-31 | Direct | 41,452 |
Reported balance
After 2026-08-14 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-08-14 · Exercise / conversion · Acquired 5,233 · Balance 41,452 F7: Represents the settlement of the third tranche of PSUs awarded to the Reporting Person in connection with her new hire grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 15, 2026, the third tranche of 5,233 performance stock units ("PSUs") awarded to the Reporting Person under the 2025 PSU Program in connection with her new hire grant vested, of which 2,662 shares were withheld to satisfy taxes.
F2: Each restricted stock unit ("RSU") represents the right to receive one share of STAAR Surgical Company ("Company") common stock upon vesting.
F3: The Reporting Person was granted Company RSUs on August 14, 2026 (the "Grant Date"). These RSUs vest as to one-third on the first anniversary of the Grant Date, and the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter.
F4: The Reporting Person was granted Issuer restricted stock units (RSUs) on August 14, 2026 (the "Grant Date"). These RSUs vest as to one-third on the first anniversary of the Grant Date, and the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter.
F5: The Reporting Person was granted an option to purchase 8,952 shares of Company common stock. The shares underlying the option vest over three years from the Grant Date, with one-third vesting on the first anniversary of the Grant Date and the remaining two-thirds vesting in 24 substantially equal monthly installment thereafter.
F6: The Reporting Person was granted a performance option to purchase 29,159 shares of Company common stock. The shares underlying the option vest over a performance period ending on the earlier of a change in control and the 10-year anniversary of the Grant Date, subject to achievement of stock-price hurdles of $50.00, $75.00 and $100.00 per share, and time vest as to one-third on the anniversary of the Grant Date with the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter.
F7: Represents the settlement of the third tranche of PSUs awarded to the Reporting Person in connection with her new hire grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionPerformance Stock Units · Derivative | 5,233 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001325697-26-000011 · ownership.xml · derivative · entry 6 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,452 Underlying: Common Stock · 5,233 shares Expires 2027-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Represents the settlement of the third tranche of PSUs awarded to the Reporting Person in connection with her new hire grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantPerformance Stock Option (right to buy) · Derivative | 29,159 | $0.00 Strike: $26.18 | $0.00 |
DisclosureSEC source: 0001325697-26-000011 · ownership.xml · derivative · entry 5 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,159 Underlying: Common Stock · 29,159 shares Expires 2036-08-13 F6 · derivative.exercise_date: The Reporting Person was granted a performance option to purchase 29,159 shares of Company common stock. The shares underlying the option vest over a performance period ending on the earlier of a change in control and the 10-year anniversary of the Grant Date, subject to achievement of stock-price hurdles of $50.00, $75.00 and $100.00 per share, and time vest as to one-third on the anniversary of the Grant Date with the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantStock Option (right to buy) · Derivative | 8,952 | $0.00 Strike: $26.18 | $0.00 |
DisclosureSEC source: 0001325697-26-000011 · ownership.xml · derivative · entry 4 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,952 Underlying: Common Stock · 8,952 shares Expires 2036-08-13 F5 · derivative.exercise_date: The Reporting Person was granted an option to purchase 8,952 shares of Company common stock. The shares underlying the option vest over three years from the Grant Date, with one-third vesting on the first anniversary of the Grant Date and the remaining two-thirds vesting in 24 substantially equal monthly installment thereafter. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 4,975 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001325697-26-000011 · ownership.xml · derivative · entry 3 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,975 Underlying: Common Stock · 4,975 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the right to receive one share of STAAR Surgical Company ("Company") common stock upon vesting. F3 · derivative.exercise_date: The Reporting Person was granted Company RSUs on August 14, 2026 (the "Grant Date"). These RSUs vest as to one-third on the first anniversary of the Grant Date, and the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter. F4 · derivative.expiration_date: The Reporting Person was granted Issuer restricted stock units (RSUs) on August 14, 2026 (the "Grant Date"). These RSUs vest as to one-third on the first anniversary of the Grant Date, and the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 2,662 | $26.18 | $69,691.16 |
DisclosureSEC source: 0001325697-26-000011 · ownership.xml · nonDerivative · entry 2 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,910 F1 · shares: On May 15, 2026, the third tranche of 5,233 performance stock units ("PSUs") awarded to the Reporting Person under the 2025 PSU Program in connection with her new hire grant vested, of which 2,662 shares were withheld to satisfy taxes. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:03 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 5,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001325697-26-000011 · ownership.xml · nonDerivative · entry 1 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:30 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionRestricted Stock Units · Derivative | 20,787 | $0.00 | $0.00 |
DisclosureSEC source: 0001325697-26-000009 · ownership.xml · derivative · entry 6 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,787 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents the vesting of RSUs granted to the Reporting Person on February 2, 2026, in connection with the Reporting Person's appointment as Interim Co-Chief Executive Officer of the Issuer on such date. The RSUs vested on July 31, 2026. The RSUs convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Represents the vesting of RSUs granted to the Reporting Person on February 2, 2026, in connection with the Reporting Person's appointment as Interim Co-Chief Executive Officer of the Issuer on such date. The RSUs vested on July 31, 2026. The RSUs convert into common stock on a one-for-one basis. F2 · derivative.expiration_date: Represents the vesting of RSUs granted to the Reporting Person on February 2, 2026, in connection with the Reporting Person's appointment as Interim Co-Chief Executive Officer of the Issuer on such date. The RSUs vested on July 31, 2026. The RSUs convert into common stock on a one-for-one basis. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:30 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 10,576 | $24.36 | $257,631.36 |
DisclosureSEC source: 0001325697-26-000009 · ownership.xml · nonDerivative · entry 4 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,339 Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:30 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 20,787 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001325697-26-000009 · ownership.xml · nonDerivative · entry 3 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,915 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the vesting of RSUs granted to the Reporting Person on February 2, 2026, in connection with the Reporting Person's appointment as Interim Co-Chief Executive Officer of the Issuer on such date. The RSUs vested on July 31, 2026. The RSUs convert into common stock on a one-for-one basis. F2 · price: Represents the vesting of RSUs granted to the Reporting Person on February 2, 2026, in connection with the Reporting Person's appointment as Interim Co-Chief Executive Officer of the Issuer on such date. The RSUs vested on July 31, 2026. The RSUs convert into common stock on a one-for-one basis. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 21:00 UTC | Lineage Cell Therapeutics, Inc. LCTX · Entity 6045 | GrantStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $1.30 | $0.00 |
DisclosureSEC source: 0001193125-26-294860 · ownership.xml · derivative · entry 1 ANDREWS DEBORAH J · CIK 0001325697 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Shares · 125,000 shares Expires 2036-07-01 F1 · derivative.exercise_date: Will vest and become exercisable on the earlier of July 1, 2027 and the date of the issuer's next annual meeting of shareholders, subject in any case to the reporting person's continuous service with the issuer. Read SEC document |
| June 25, 2026 Filed Aug 4, 2026 20:30 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionRestricted Stock Units · Derivative | 13,955 | $0.00 | $0.00 |
DisclosureSEC source: 0001325697-26-000009 · ownership.xml · derivative · entry 5 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,912 Underlying: Common Stock · 13,955 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents the vesting of restricted stock units ("RSUs") granted to the Reporting Person on June 25, 2025, in connection with her appointment as Chief Financial Officer of the Issuer on such date. These RSUs vest as to 1/3 of the shares subject to the award on each of June 25, 2026, 2027 and 2028. The RSUs convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Represents the vesting of restricted stock units ("RSUs") granted to the Reporting Person on June 25, 2025, in connection with her appointment as Chief Financial Officer of the Issuer on such date. These RSUs vest as to 1/3 of the shares subject to the award on each of June 25, 2026, 2027 and 2028. The RSUs convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Represents the vesting of restricted stock units ("RSUs") granted to the Reporting Person on June 25, 2025, in connection with her appointment as Chief Financial Officer of the Issuer on such date. These RSUs vest as to 1/3 of the shares subject to the award on each of June 25, 2026, 2027 and 2028. The RSUs convert into common stock on a one-for-one basis. Read SEC document |
| June 25, 2026 Filed Aug 4, 2026 20:30 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 6,480 | $31.21 | $202,240.80 |
DisclosureSEC source: 0001325697-26-000009 · ownership.xml · nonDerivative · entry 2 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,128 Read SEC document |
| June 25, 2026 Filed Aug 4, 2026 20:30 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 13,955 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001325697-26-000009 · ownership.xml · nonDerivative · entry 1 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the vesting of restricted stock units ("RSUs") granted to the Reporting Person on June 25, 2025, in connection with her appointment as Chief Financial Officer of the Issuer on such date. These RSUs vest as to 1/3 of the shares subject to the award on each of June 25, 2026, 2027 and 2028. The RSUs convert into common stock on a one-for-one basis. F1 · price: Represents the vesting of restricted stock units ("RSUs") granted to the Reporting Person on June 25, 2025, in connection with her appointment as Chief Financial Officer of the Issuer on such date. These RSUs vest as to 1/3 of the shares subject to the award on each of June 25, 2026, 2027 and 2028. The RSUs convert into common stock on a one-for-one basis. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionPerformance Stock Units · Derivative | 5,233 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001325697-26-000006 · ownership.xml · derivative · entry 6 ANDREWS DEBORAH J · CIK 0001325697 · Interim Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,699 Underlying: Common Stock · 5,233 shares Expires 2027-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Represents the settlement of the second tranche of performance stock units awarded to the Reporting Person in connection with her new hire grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionPerformance Stock Units · Derivative | 10,466 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001325697-26-000006 · ownership.xml · derivative · entry 5 ANDREWS DEBORAH J · CIK 0001325697 · Interim Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,466 Underlying: Common Stock · 10,466 shares Expires 2027-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents the settlement of the first tranche of performance stock units awarded to the Reporting Person in connection with her new hire grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 1,877 | $32.07 | $60,195.39 |
DisclosureSEC source: 0001325697-26-000006 · ownership.xml · nonDerivative · entry 4 ANDREWS DEBORAH J · CIK 0001325697 · Interim Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,653 F2 · shares: On May 15, 2026, the second tranche of 5,233 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with her new hire grant vested, of which 1,877 shares were withheld to satisfy taxes. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock | 5,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001325697-26-000006 · ownership.xml · nonDerivative · entry 3 ANDREWS DEBORAH J · CIK 0001325697 · Interim Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,530 Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Tax withholdingCommon Stock | 3,755 | $32.07 | $120,422.85 |
DisclosureSEC source: 0001325697-26-000006 · ownership.xml · nonDerivative · entry 2 ANDREWS DEBORAH J · CIK 0001325697 · Interim Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,297 F1 · shares: On May 15, 2026, the first tranche of 10,466 performance stock units ("PSUs") awarded to the Reporting Person under the Issuer's 2025 Performance Stock Unit Award Program ("2025 PSU Program") in connection with her new hire grant vested, of which 3,755 shares were withheld to satisfy taxes . Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:01 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock | 10,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001325697-26-000006 · ownership.xml · nonDerivative · entry 1 ANDREWS DEBORAH J · CIK 0001325697 · Interim Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,466 Read SEC document |
| March 13, 2026 Filed Mar 16, 2026 21:00 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 39,809 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001325697-26-000002 · ownership.xml · derivative · entry 1 ANDREWS DEBORAH J · CIK 0001325697 · Interim Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,809 Underlying: Common Stock · 39,809 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting. F2 · derivative.exercise_date: Reflects RSUs granted to the Reporting Person on March 13, 2026 in connection with annual equity award. These RSUs vest as to 1/3 (13,269 shares) on March 13, 2027, 1/3 (13,270 shares) on March 13, 2028, and 1/3 (13,270 shares) on March 13, 2029. F2 · derivative.expiration_date: Reflects RSUs granted to the Reporting Person on March 13, 2026 in connection with annual equity award. These RSUs vest as to 1/3 (13,269 shares) on March 13, 2027, 1/3 (13,270 shares) on March 13, 2028, and 1/3 (13,270 shares) on March 13, 2029. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 22:28 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 20,787 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-037865 · ownership.xml · derivative · entry 1 ANDREWS DEBORAH J · CIK 0001325697 · Interim Co-CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,787 Underlying: Common Stock · 20,787 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting. F2 · derivative.exercise_date: Award of RSUs granted to the Reporting Person on February 2, 2026. These RSUs will vest as to 100% of the shares subject thereto on August 1, 2026. F2 · derivative.expiration_date: Award of RSUs granted to the Reporting Person on February 2, 2026. These RSUs will vest as to 100% of the shares subject thereto on August 1, 2026. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 01:00 UTC | Lineage Cell Therapeutics, Inc. LCTX · Entity 6045 | GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0000950170-25-093466 · ownership.xml · derivative · entry 1 ANDREWS DEBORAH J · CIK 0001325697 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Shares · 75,000 shares Expires 2035-07-01 F1 · derivative.exercise_date: Will vest and become exercisable on the earlier of July 1, 2026 and the date of the issuer's next annual meeting of shareholders, subject in any case to the reporting person's continuous service with the issuer. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 22:31 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 41,867 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-090534 · ownership.xml · derivative · entry 1 ANDREWS DEBORAH J · CIK 0001325697 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,867 Underlying: Common Stock · 41,867 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting. F2 · derivative.exercise_date: Award of RSUs granted to the Reporting Person on June 25, 2025. These RSUs will vest as to 1/3 of the shares subject to the award on each of June 25, 2026, 2027 and 2028. F2 · derivative.expiration_date: Award of RSUs granted to the Reporting Person on June 25, 2025. These RSUs will vest as to 1/3 of the shares subject to the award on each of June 25, 2026, 2027 and 2028. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 21:00 UTC | Lineage Cell Therapeutics, Inc. LCTX · Entity 6045 | GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0000950170-24-081602 · ownership.xml · derivative · entry 1 ANDREWS DEBORAH J · CIK 0001325697 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Shares · 75,000 shares Expires 2034-07-01 F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2025, subject to the reporting person's continuous service with the issuer. Read SEC document |
| July 01, 2023 Filed Jul 3, 2023 21:46 UTC | Lineage Cell Therapeutics, Inc. LCTX · Entity 6045 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001493152-23-023343 · ownership.xml · derivative · entry 1 ANDREWS DEBORAH J · CIK 0001325697 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Shares · 50,000 shares Expires 2033-07-01 F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2024, subject to the reporting person's continuous service with the issuer. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 20:15 UTC | Lineage Cell Therapeutics, Inc. LCTX · Entity 6045 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0001493152-22-018684 · ownership.xml · derivative · entry 1 ANDREWS DEBORAH J · CIK 0001325697 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Shares · 50,000 shares Expires 2032-07-01 F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2023, subject to the reporting person's continuous service with the issuer. Read SEC document |
| July 01, 2021 Filed Jul 1, 2021 22:29 UTC | Lineage Cell Therapeutics, Inc. LCTX · Entity 6045 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.86 | $0.00 |
DisclosureSEC source: 0001493152-21-015890 · ownership.xml · derivative · entry 1 ANDREWS DEBORAH J · CIK 0001325697 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Shares · 50,000 shares Expires 2031-07-01 F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2022, subject to the reporting person's continuous service with the issuer. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 23:01 UTC | Lineage Cell Therapeutics, Inc. LCTX · Entity 6045 | Exercise / conversionStock Option (right to buy) · Derivative | 24,720 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001493152-21-015788 · ownership.xml · derivative · entry 3 ANDREWS DEBORAH J · CIK 0001325697 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 24,720 shares Expires 2021-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option became exercisable in four equal quarterly installments after the date of grant on July 1, 2016 Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 23:01 UTC | Lineage Cell Therapeutics, Inc. LCTX · Entity 6045 | SaleCommon Shares, no par value | 19,142 | $2.93 | $56,086.06 |
DisclosureSEC source: 0001493152-21-015788 · ownership.xml · nonDerivative · entry 2 ANDREWS DEBORAH J · CIK 0001325697 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,578 F1 · price: The price reported is a weighted average. These shares were sold in multiple transactions at a price of $2.93 or $2.935. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| June 29, 2021 Filed Jun 30, 2021 23:01 UTC | Lineage Cell Therapeutics, Inc. LCTX · Entity 6045 | Exercise / conversionCommon Shares, no par value | 24,720 | $2.20 | $54,384.00 |
DisclosureSEC source: 0001493152-21-015788 · ownership.xml · nonDerivative · entry 1 ANDREWS DEBORAH J · CIK 0001325697 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 21:02 UTC | Lineage Cell Therapeutics, Inc. LCTX · Entity 6045 | GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001493152-20-012536 · ownership.xml · derivative · entry 1 ANDREWS DEBORAH J · CIK 0001325697 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Shares · 40,000 shares Expires 2030-07-01 F1 · derivative.exercise_date: Will become exercisable on July 1, 2021, based upon continued service on the board of directors. Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 20:09 UTC | STAAR SURGICAL CO STAA · Entity 4851 | SaleCommon Stock | 834 | $27.42 | $22,868.28 |
DisclosureSEC source: 0001209191-20-020910 · doc4.xml · nonDerivative · entry 1 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,267 Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 3,370 | $0.00 Strike: $29.80 | $0.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · derivative · entry 19 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188 Underlying: Common Stock · 3,370 shares Expires 2021-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 06/14/2019, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 06/14/2021. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 7,291 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · derivative · entry 18 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347 Underlying: Common Stock · 7,291 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 03/15/2019, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 03/15/2021. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 17,360 | $0.00 Strike: $15.25 | $0.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · derivative · entry 17 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 695 Underlying: Common Stock · 17,360 shares Expires 2027-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 11/13/2018, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 11/13/2020. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 4,583 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · derivative · entry 16 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139 Underlying: Common Stock · 4,583 shares Expires 2027-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The options granted become exercisable as follows: 1/3 on 03/21/2018, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 03/21/2020. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 9,000 | $0.00 Strike: $7.36 | $0.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · derivative · entry 15 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,000 shares Expires 2026-04-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The options granted became exercisable as follows: 1/3 on 04/04/2017, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted became exercisable on 04/04/2019. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 15,000 | $0.00 Strike: $7.35 | $0.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · derivative · entry 14 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2025-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These stock options became exercisable in three equal annual installments on April 7, 2016, April 7, 2017, and April 7, 2018. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 10,000 | $0.00 Strike: $15.54 | $0.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · derivative · entry 13 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2024-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These stock options became exercisable in three equal annual installments on March 7, 2015, March 7, 2016, and March 7, 2017. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 20,000 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · derivative · entry 12 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2023-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These stock options became exercisable in three equal annual installments on March 4, 2014, March 4, 2015, and March 4, 2016. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock Options · Derivative | 20,000 | $0.00 Strike: $11.00 | $0.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · derivative · entry 11 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2022-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These stock options became exercisable in three equal annual installments on March 4, 2014, March 4, 2015, and March 4, 2016. F3 · derivative.exercise_date: These stock options became exercisable in three equal annual installments on March 2, 2013, March 2, 2014, and March 2, 2015. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC | STAAR SURGICAL CO STAA · Entity 4851 | SaleCommon Stock | 106,604 | $42.20 | $4,498,688.80 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · nonDerivative · entry 10 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,101 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.86 to $42.53, inclusive. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 3,370 | $29.80 | $100,426.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · nonDerivative · entry 9 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 7,291 | $16.15 | $117,749.65 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · nonDerivative · entry 8 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 17,360 | $15.25 | $264,740.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · nonDerivative · entry 7 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 4,583 | $9.30 | $42,621.90 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · nonDerivative · entry 6 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,684 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 9,000 | $7.36 | $66,240.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · nonDerivative · entry 5 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 15,000 | $7.35 | $110,250.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · nonDerivative · entry 4 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 10,000 | $15.54 | $155,400.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · nonDerivative · entry 3 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:06 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 20,000 | $5.34 | $106,800.00 |
DisclosureSEC source: 0001209191-20-004627 · doc4.xml · nonDerivative · entry 2 ANDREWS DEBORAH J · CIK 0001325697 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.